Revolution in cancer treatment: AI supports decisions of the doctors!

Revolution in cancer treatment: AI supports decisions of the doctors!

Linz, Österreich - A groundbreaking innovation in cancer treatment could soon change the lives of many patients. A research team around the urologist Thomas Höfner from the Linz Ordensklinikum Elisabethinen has developed an innovative AI system that supports medical teams in the therapy decision for urothelial carcinomas and renal cell carcinomas. This development was realized in cooperation with the Mainz University Hospital and the German Research Center for Artificial Intelligence and is based on comprehensive data analyzes of almost 2,500 real treatment cases. today.at reports that the system aims to facilitate the complex therapy process and to optimize the treatment of patients.

The AI ​​technology can take over 90 clinical parameters per patient and provide recommendations for treatment approaches that are evidence-based. The software transparently shows the reasons for your suggestions, be it for surgery or the administration of medication such as Pembrolizumab. Above all, the SHAP method, which contributes to the explanability of decision-making, ensures that teams of doctors can easily understand the background of the therapy recommendations. This not only leads to transparency, but also ensures that the proposed therapies can be clinically usable.

a milestone in oncology

The international research team reports this development a significant step in clinical oncology. The results of the project were published in the European Journal of Cancer and underline how artificial intelligence can not only optimize decision -making in medicine, but also improve patient care. [Ordensklinikum.at] (https://www.ordensklinikum.at/de/aktuelles/weltpremiere-erklaerbare-kuenstliche-intelligenz- Unterstuetzt-Mals therapy decisions-in-er-uro-onkology-2370/) emphasizes that both general and specific treatment recommendations are provided, even for rare Therapy options.

The AI ​​is used in a special, user -friendly dashboard that was developed for everyday clinical life. Despite this state -of -the -art support, the final decision always remains with the treating team. This shows that the development is an important tool, but the human expertise remains essential. The next steps provide for further prospective validation studies and an expansion of the system to additional types of tumor such as prostate cancer. In the future, more affected people could benefit from intelligent technology.

The digital revolution in medicine

Digitization and dealing with large amounts of data, often referred to as big data, are also of interest in the medicine. [fraunhofer.de] (https://www.iks.fraunhofer.de/de/themen/kuenstliche-intelligenz/kuenstliche-intliche-intigenz- Medicine.html) indicates that efficient data networking not only enables the monitoring of processes, but also leads to individual and rational therapy decisions. Artificial intelligence becomes the key. It accelerates the analysis and combination of extensive databases and thereby improves the diagnostic possibilities and medical care as a whole.

While the technologies of the future, such as AI, now also find their way into cancer medicine, it can be seen that progress in oncology could have far -reaching effects on the care of the patients. These developments give us hope that innovative approaches will increase the chances of healing in urothelial carcinomas and renal cell carcinomas.